Global MIS Sacroiliac Joint Fusion Market By Diagnosis (Provocative Tests – Distraction, Thigh Thrust, Compression, FABER, Gaenslen, Diagnostic Imaging (X-ray, CT, MRI), Diagnostic SI Joint Injections of the SI Joint – Fluoroscopic Guided SI Joint Injection, Post-injection Pain Reduction); By Cause (Sacroiliac Trauma – Motor Vehicle Accident, Fall on Buttock, Lifting and/ or Twisting, Natural Childbirth, Pregnancy, Others, Sacroiliac Joint Degeneration – Previous Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae), Stresses to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis, Osteoarthritis, Previous iliac Crest Bone Graft (ICBG), Prior Infection of the SI joint, Others, Others); By Treatment (Conservative Therapies, Non-Surgical SI Joint Treatment Options – Pain Medications (NSAIDs, Opiods, or other medications), Chiropractic Care, Physical Therapy, Yoga, Massage Therapy, Therapeutic SI Joint Injections, RF Denervation or Radiofrequency Ablation (RFA), SI Joint Belts, Others, Minimally Invasive SI joint fusion Surgery, Open Surgery of Sacroiliac Joint Fusion); By End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global MIS sacroiliac joint fusion market was valued at in 2021 and is expected to reach by 2029, growing at an estimated CAGR of over the forecast period. Every time we think of the human body, its formation amuses every single time. Every body part has its significance, and utterly important role to play in the mechanism. The sacroiliac joint (SI joint) happens to be a joint that is located in the pelvis region, where it connects the iliac bones (pelvis) with the sacrum (lowest part of the spine located right above the tailbone). The SI joint is extremely important as it helps in the transfer of energy between the legs and the torso. As this joint function relentlessly, it is likely to incur some sort of damage, which cause pain. The signs and symptoms of SI pain commences from the lower back and buttock, and is likely to radiate towards the lower hip, groin or upper thigh. Owing to strenuous lifestyles, the number of people suffering from this ailment are growing and thus helping the global MIS sacroiliac joint fusion market grow aggressively.
Global MIS sacroiliac joint fusion market was adversely impacted during the period of the COVID-19 pandemic. Unavailability of beds and medical professionals in majority of countries was the reason behind it. In terms of CAGR, the global MIS sacroiliac joint fusion market was worth US$ 290.8 Mn in 2021 and is forecasted to gain CAGR of 15.5% over the forecast period.
Global MIS Sacroiliac Joint Fusion Market Revenue & Forecast, (US$ Million), 2022 – 2030
By Diagnosis
On the basis of diagnosis, the global MIS sacroiliac joint fusion market has been bifurcated into provocative tests, diagnostic Imaging (X-ray, CT, MRI), and diagnostic SI Joint Injections of the SI Joint. The provocative tests segment is further bifurcated into distraction, thigh thrust, compression, FABER, and Gaenslen, while the diagnostic SI Joint Injections of the SI Joint is fragmented into fluoroscopic guided SI joint injection, and post-injection pain reduction. The diagnostic imaging segment accounts for majority of revenue generated by this market as imaging techniques like X-ray, CT and MRI are easy to be done and affordable.
By Cause
On the basis of cause, the global MIS sacroiliac joint fusion market has been bifurcated into sacroiliac trauma and sacroiliac joint degeneration. While the sacroiliac trauma that is usually caused due to disruption of the SI joint is further categorised into motor vehicle accident, fall on buttock, lifting and/ or twisting, natural childbirth, pregnancy, and others, the sacroiliac joint generation segment is bifurcated into previous lumbar spine surgery (e.g. fusion of the lumbar vertebrae), stresses to the SI joint due to leg length differences, joint replacement, or scoliosis, osteoarthritis, previous iliac crest bone graft (ICBG), prior Infection of the SI joint, and others. This segment mints maximum amount of money for this market as majority of the causes in this segment can be caused naturally.
By Treatments
On the basis of treatments, the global MIS sacroiliac joint fusion market has been divided into conservative therapies, non-surgical SI joint treatment options, minimally invasive SI joint fusion surgery and open surgery of sacroiliac joint fusion. The non-surgical SI joint treatment options segment is further bifurcated into pain medications (NSAIDs, opiods, or other medications), chiropractic care, physical therapy, yoga, massage therapy, therapeutic SI joint injections, RF denervation or radiofrequency ablation (RFA), SI joint belts, and others. The minimally invasive SI joint fusion segment has been dominating in terms of market share.
By End Users
On the basis of the end users, the global MIS sacroiliac joint fusion market has been bifurcated into hospitals, clinics, ambulatory surgical centers and others. The hospitals segment holds major share of revenue for the market. This is because number of people opting to get themselves treated at hospitals is relatively high compared to other places.
By Region
On the basis of region, the global MIS sacroiliac joint fusion market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of North America emerges as the winner in terms of making money for the market. This is because of higher spending capacity of people in countries like the United States and Canada.
Competitive Landscape
The report provides both, qualitative and quantitative research of global MIS sacroiliac joint fusion market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global MIS sacroiliac joint fusion market are listed below:
- Globus Medical
- Life Spine, Inc.
- Medtronic
- Orthofix Medical Inc.
- SI-BONE, Inc.
- Surgalign
- VGI MEDICAL
- XTANT MEDICAL
- Zimmer Biomet
- Other Market Participants
Global MIS Sacroiliac Joint Fusion Market
By Diagnosis
- Provocative Tests
- Distraction
- Thigh Thrust
- Compression
- FABER
- Gaenslen
- Diagnostic Imaging (X-ray, CT, MRI)
- Diagnostic SI Joint Injections of the SI Joint
- Fluoroscopic Guided SI Joint Injection
- Post-injection Pain Reduction
By Cause
- Sacroiliac Trauma
- Motor Vehicle Accident
- Fall on Buttock
- Lifting and/ or Twisting
- Natural Childbirth
- Pregnancy
- Others
- Sacroiliac Joint Degeneration
- Previous Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
- Stresses to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
- Osteoarthritis
- Previous iliac Crest Bone Graft (ICBG)
- Prior Infection of the SI joint
- Others
- Others
By Treatments
- Conservative Therapies
- Non-Surgical SI Joint Treatment Options
- Pain Medications (NSAIDs, opiods, or other medications)
- Chiropractic Care
- Physical Therapy
- Yoga
- Massage Therapy
- Therapeutic SI Joint Injections
- RF Denervation or Radiofrequency Ablation (RFA)
- SI Joint Belts
- Others
- Minimally Invasive SI joint fusion Surgery
- Open Surgery of Sacroiliac Joint Fusion
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1.
Historic
Years: 2015 - 2020
1.2.2.
Base
Year: 2021
1.2.3.
Forecast
Years: 2022 - 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1.
Research
Questionnaire
3.1.2.
Global
Percentage Breakdown
3.1.3.
Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1.
Paid
Databases
3.2.2.
Secondary
Sources
3.3. Market Size Estimates
3.3.1.
Top-Down
Approach
3.3.2.
Bottom-Up
Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of MIS Sacroiliac Joint Fusion Market
6.
Market
Synopsis: MIS Sacroiliac Joint Fusion
Market
7.
MIS
Sacroiliac Joint Fusion Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1.
Product
Definition
7.1.2.
Industry
Development
7.2. Market Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.2.4.
Challenges
7.3. Trends in MIS Sacroiliac Joint Fusion Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
MIS Sacroiliac Joint Fusion Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on MIS Sacroiliac Joint
Fusion Market
8.
Global
MIS Sacroiliac Joint Fusion Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1.
Global
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn)
8.2. Global MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Diagnosis
8.2.1.
Provocative
Tests (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
- 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Distraction, Thigh Thrust, Compression, FABER, Gaenslen)
8.2.1.1.
Distraction
8.2.1.2.
Thigh
Thrust
8.2.1.3.
Compression
8.2.1.4.
FABER
8.2.1.5.
Gaenslen
8.2.2.
Diagnostic
Imaging (X-ray, CT, MRI)
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.2.3.
Diagnostic
SI Joint Injections of the SI Joint (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
- 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Fluoroscopic Guided SI Joint Injection, Post-injection Pain
Reduction)
8.2.3.1.
Fluoroscopic
Guided SI Joint Injection
8.2.3.2.
Post-injection
Pain Reduction
8.3. Key Segment for Channeling Investments
8.3.1.
By
Diagnosis
9.
Global
MIS Sacroiliac Joint Fusion Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Cause
9.2.1.
Sacroiliac
Trauma (Definition, Market Estimation and Penetration, 2015 - 2021, Market
Estimation (2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Motor Vehicle Accident, Fall
on Buttock, Lifting and/ or Twisting, Natural Childbirth, Pregnancy, Others)
9.2.1.1.
Motor
Vehicle Accident
9.2.1.2.
Fall on
Buttock
9.2.1.3.
Lifting
and/ or Twisting
9.2.1.4.
Natural
Childbirth
9.2.1.5.
Pregnancy
9.2.1.6.
Others
9.2.2.
Sacroiliac
Joint Degeneration (Definition, Market Estimation and Penetration, 2015 - 2021,
Market Estimation (2015 - 2021), Market Forecast (2022 - 2030), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Previous Lumbar Spine
Surgery (e.g. fusion of the lumbar vertebrae), Stresses to the SI Joint due to
Leg Length Differences, Joint Replacement, or Scoliosis, Osteoarthritis,
Previous iliac Crest Bone Graft (ICBG), Prior Infection of the SI joint,
Others)
9.2.2.1.
Previous
Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
9.2.2.2.
Stresses
to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
9.2.2.3.
Osteoarthritis
9.2.2.4.
Previous
iliac Crest Bone Graft (ICBG)
9.2.2.5.
Prior
Infection of the SI joint
9.2.2.6.
Others
9.2.3.
Others
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1.
By Cause
10. Global MIS Sacroiliac Joint Fusion Market
Analysis and Forecasts, 2022 - 2030
10.1. Overview
10.2. Global MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Treatments
10.2.1. Conservative Therapies
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Non-Surgical SI Joint Treatment Options
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Pain Medications (NSAIDs, opiods,
or other medications), Chiropractic Care, Physical Therapy, Yoga, Massage Therapy,
Therapeutic SI Joint Injections, RF Denervation or Radiofrequency Ablation
(RFA), SI Joint Belts, Others)
10.2.2.1.
Pain
Medications (NSAIDs, opiods, or other medications)
10.2.2.2.
Chiropractic
Care
10.2.2.3.
Physical
Therapy
10.2.2.4.
Yoga
10.2.2.5.
Massage
Therapy
10.2.2.6.
Therapeutic
SI Joint Injections
10.2.2.7.
RF
Denervation or Radiofrequency Ablation (RFA)
10.2.2.8.
SI Joint
Belts
10.2.2.9.
Others
10.2.3. Minimally Invasive SI joint fusion Surgery
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Open Surgery of Sacroiliac Joint Fusion
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 - 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Treatments
11. Global MIS Sacroiliac Joint Fusion Market
Analysis and Forecasts, 2022 - 2030
11.1. Overview
11.2. Global MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Hospitals
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 - 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 - 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 - 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 - 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 - 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 - 2030
11.2.2. Clinics
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 - 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 - 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 - 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 - 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 - 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 - 2030
11.2.3. Ambulatory Surgical Centers
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 - 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 - 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 - 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 - 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 - 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 - 2030
11.2.4. Others
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 - 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 - 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 - 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 - 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 - 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 - 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End User
12. North America MIS Sacroiliac Joint Fusion
Market Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. North America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn)
12.2. North America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.2.1. Provocative Tests
12.2.1.1.
Distraction
12.2.1.2.
Thigh
Thrust
12.2.1.3.
Compression
12.2.1.4.
FABER
12.2.1.5.
Gaenslen
12.2.2. Diagnostic Imaging (X-ray, CT, MRI)
12.2.3. Diagnostic SI Joint Injections of the SI
Joint
12.2.3.1.
Fluoroscopic
Guided SI Joint Injection
12.2.3.2.
Post-injection
Pain Reduction
12.3. North America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Cause
12.3.1. Sacroiliac Trauma
12.3.1.1.
Motor
Vehicle Accident
12.3.1.2.
Fall on
Buttock
12.3.1.3.
Lifting
and/ or Twisting
12.3.1.4.
Natural
Childbirth
12.3.1.5.
Pregnancy
12.3.1.6.
Others
12.3.2. Sacroiliac Joint Degeneration
12.3.2.1.
Previous
Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
12.3.2.2.
Stresses
to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
12.3.2.3.
Osteoarthritis
12.3.2.4.
Previous
iliac Crest Bone Graft (ICBG)
12.3.2.5.
Prior
Infection of the SI joint
12.3.2.6.
Others
12.3.3. Others
12.4. North America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Treatments
12.4.1. Conservative Therapies
12.4.2. Non-Surgical SI Joint Treatment Options
12.4.2.1.
Pain
Medications (NSAIDs, opiods, or other medications)
12.4.2.2.
Chiropractic
Care
12.4.2.3.
Physical
Therapy
12.4.2.4.
Yoga
12.4.2.5.
Massage
Therapy
12.4.2.6.
Therapeutic
SI Joint Injections
12.4.2.7.
RF
Denervation or Radiofrequency Ablation (RFA)
12.4.2.8.
SI Joint
Belts
12.4.2.9.
Others
12.4.3. Minimally Invasive SI joint fusion Surgery
12.4.4. Open Surgery of Sacroiliac Joint Fusion
12.5. North America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. North America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.6.1.1.1.
Provocative
Tests
12.6.1.1.1.1. Distraction
12.6.1.1.1.2. Thigh Thrust
12.6.1.1.1.3. Compression
12.6.1.1.1.4. FABER
12.6.1.1.1.5. Gaenslen
12.6.1.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
12.6.1.1.3.
Diagnostic
SI Joint Injections of the SI Joint
12.6.1.1.3.1. Fluoroscopic Guided SI Joint Injection
12.6.1.1.3.2. Post-injection Pain Reduction
12.6.1.2.
U.S MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
12.6.1.2.1.
Sacroiliac
Trauma
12.6.1.2.1.1. Motor Vehicle Accident
12.6.1.2.1.2. Fall on Buttock
12.6.1.2.1.3. Lifting and/ or Twisting
12.6.1.2.1.4. Natural Childbirth
12.6.1.2.1.5. Pregnancy
12.6.1.2.1.6. Others
12.6.1.2.2.
Sacroiliac
Joint Degeneration
12.6.1.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
12.6.1.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
12.6.1.2.2.3. Osteoarthritis
12.6.1.2.2.4. Previous iliac Crest Bone Graft (ICBG)
12.6.1.2.2.5. Prior Infection of the SI joint
12.6.1.2.2.6. Others
12.6.1.2.3.
Others
12.6.1.3.
U.S MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Treatments
12.6.1.3.1.
Conservative
Therapies
12.6.1.3.2.
Non-Surgical
SI Joint Treatment Options
12.6.1.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
12.6.1.3.2.2. Chiropractic Care
12.6.1.3.2.3. Physical Therapy
12.6.1.3.2.4. Yoga
12.6.1.3.2.5. Massage Therapy
12.6.1.3.2.6. Therapeutic SI Joint Injections
12.6.1.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
12.6.1.3.2.8. SI Joint Belts
12.6.1.3.2.9. Others
12.6.1.3.3.
Minimally
Invasive SI joint fusion Surgery
12.6.1.3.4.
Open
Surgery of Sacroiliac Joint Fusion
12.6.1.4.
U.S MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
12.6.1.4.1.
Hospitals
12.6.1.4.2.
Clinics
12.6.1.4.3.
Ambulatory
Surgical Centers
12.6.1.4.4.
Others
12.6.2. Canada
12.6.2.1.
Canada
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.6.2.1.1.
Provocative
Tests
12.6.2.1.1.1. Distraction
12.6.2.1.1.2. Thigh Thrust
12.6.2.1.1.3. Compression
12.6.2.1.1.4. FABER
12.6.2.1.1.5. Gaenslen
12.6.2.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
12.6.2.1.3.
Diagnostic
SI Joint Injections of the SI Joint
12.6.2.1.3.1. Fluoroscopic Guided SI Joint Injection
12.6.2.1.3.2. Post-injection Pain Reduction
12.6.2.2.
Canada
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
12.6.2.2.1.
Sacroiliac
Trauma
12.6.2.2.1.1. Motor Vehicle Accident
12.6.2.2.1.2. Fall on Buttock
12.6.2.2.1.3. Lifting and/ or Twisting
12.6.2.2.1.4. Natural Childbirth
12.6.2.2.1.5. Pregnancy
12.6.2.2.1.6. Others
12.6.2.2.2.
Sacroiliac
Joint Degeneration
12.6.2.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
12.6.2.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
12.6.2.2.2.3. Osteoarthritis
12.6.2.2.2.4. Previous iliac Crest Bone Graft (ICBG)
12.6.2.2.2.5. Prior Infection of the SI joint
12.6.2.2.2.6. Others
12.6.2.2.3.
Others
12.6.2.3.
Canada
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
12.6.2.3.1.
Conservative
Therapies
12.6.2.3.2.
Non-Surgical
SI Joint Treatment Options
12.6.2.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
12.6.2.3.2.2. Chiropractic Care
12.6.2.3.2.3. Physical Therapy
12.6.2.3.2.4. Yoga
12.6.2.3.2.5. Massage Therapy
12.6.2.3.2.6. Therapeutic SI Joint Injections
12.6.2.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
12.6.2.3.2.8. SI Joint Belts
12.6.2.3.2.9. Others
12.6.2.3.3.
Minimally
Invasive SI joint fusion Surgery
12.6.2.3.4.
Open
Surgery of Sacroiliac Joint Fusion
12.6.2.4.
Canada
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
12.6.2.4.1.
Hospitals
12.6.2.4.2.
Clinics
12.6.2.4.3.
Ambulatory
Surgical Centers
12.6.2.4.4.
Others
12.6.3. Mexico
12.6.3.1.
Mexico
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.6.3.1.1.
Provocative
Tests
12.6.3.1.1.1. Distraction
12.6.3.1.1.2. Thigh Thrust
12.6.3.1.1.3. Compression
12.6.3.1.1.4. FABER
12.6.3.1.1.5. Gaenslen
12.6.3.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
12.6.3.1.3.
Diagnostic
SI Joint Injections of the SI Joint
12.6.3.1.3.1. Fluoroscopic Guided SI Joint Injection
12.6.3.1.3.2. Post-injection Pain Reduction
12.6.3.2.
Mexico
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
12.6.3.2.1.
Sacroiliac
Trauma
12.6.3.2.1.1. Motor Vehicle Accident
12.6.3.2.1.2. Fall on Buttock
12.6.3.2.1.3. Lifting and/ or Twisting
12.6.3.2.1.4. Natural Childbirth
12.6.3.2.1.5. Pregnancy
12.6.3.2.1.6. Others
12.6.3.2.2.
Sacroiliac
Joint Degeneration
12.6.3.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
12.6.3.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
12.6.3.2.2.3. Osteoarthritis
12.6.3.2.2.4. Previous iliac Crest Bone Graft (ICBG)
12.6.3.2.2.5. Prior Infection of the SI joint
12.6.3.2.2.6. Others
12.6.3.2.3.
Others
12.6.3.3.
Mexico
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
12.6.3.3.1.
Conservative
Therapies
12.6.3.3.2.
Non-Surgical
SI Joint Treatment Options
12.6.3.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
12.6.3.3.2.2. Chiropractic Care
12.6.3.3.2.3. Physical Therapy
12.6.3.3.2.4. Yoga
12.6.3.3.2.5. Massage Therapy
12.6.3.3.2.6. Therapeutic SI Joint Injections
12.6.3.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
12.6.3.3.2.8. SI Joint Belts
12.6.3.3.2.9. Others
12.6.3.3.3.
Minimally
Invasive SI joint fusion Surgery
12.6.3.3.4.
Open
Surgery of Sacroiliac Joint Fusion
12.6.3.4.
Mexico
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
12.6.3.4.1.
Hospitals
12.6.3.4.2.
Clinics
12.6.3.4.3.
Ambulatory
Surgical Centers
12.6.3.4.4.
Others
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
12.6.4.1.1.
Provocative
Tests
12.6.4.1.1.1. Distraction
12.6.4.1.1.2. Thigh Thrust
12.6.4.1.1.3. Compression
12.6.4.1.1.4. FABER
12.6.4.1.1.5. Gaenslen
12.6.4.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
12.6.4.1.3.
Diagnostic
SI Joint Injections of the SI Joint
12.6.4.1.3.1. Fluoroscopic Guided SI Joint Injection
12.6.4.1.3.2. Post-injection Pain Reduction
12.6.4.2.
Rest of
North America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By Cause
12.6.4.2.1.
Sacroiliac
Trauma
12.6.4.2.1.1. Motor Vehicle Accident
12.6.4.2.1.2. Fall on Buttock
12.6.4.2.1.3. Lifting and/ or Twisting
12.6.4.2.1.4. Natural Childbirth
12.6.4.2.1.5. Pregnancy
12.6.4.2.1.6. Others
12.6.4.2.2.
Sacroiliac
Joint Degeneration
12.6.4.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
12.6.4.2.2.2. Stresses to the SI Joint due to Leg Length Differences,
Joint Replacement, or Scoliosis
12.6.4.2.2.3. Osteoarthritis
12.6.4.2.2.4. Previous iliac Crest Bone Graft (ICBG)
12.6.4.2.2.5. Prior Infection of the SI joint
12.6.4.2.2.6. Others
12.6.4.2.3.
Others
12.6.4.3.
Rest of
North America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By Treatments
12.6.4.3.1.
Conservative
Therapies
12.6.4.3.2.
Non-Surgical
SI Joint Treatment Options
12.6.4.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
12.6.4.3.2.2. Chiropractic Care
12.6.4.3.2.3. Physical Therapy
12.6.4.3.2.4. Yoga
12.6.4.3.2.5. Massage Therapy
12.6.4.3.2.6. Therapeutic SI Joint Injections
12.6.4.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
12.6.4.3.2.8. SI Joint Belts
12.6.4.3.2.9. Others
12.6.4.3.3.
Minimally
Invasive SI joint fusion Surgery
12.6.4.3.4.
Open
Surgery of Sacroiliac Joint Fusion
12.6.4.4.
Rest of
North America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.4.4.1.
Hospitals
12.6.4.4.2.
Clinics
12.6.4.4.3.
Ambulatory
Surgical Centers
12.6.4.4.4.
Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Diagnosis
12.7.3. By Cause
12.7.4. By Treatments
12.7.5. By End User
13. Europe MIS Sacroiliac Joint Fusion Market
Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Europe MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn)
13.2. Europe MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Diagnosis
13.2.1. Provocative Tests
13.2.1.1.
Distraction
13.2.1.2.
Thigh
Thrust
13.2.1.3.
Compression
13.2.1.4.
FABER
13.2.1.5.
Gaenslen
13.2.2. Diagnostic Imaging (X-ray, CT, MRI)
13.2.3. Diagnostic SI Joint Injections of the SI
Joint
13.2.3.1.
Fluoroscopic
Guided SI Joint Injection
13.2.3.2.
Post-injection
Pain Reduction
13.3. Europe MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Cause
13.3.1. Sacroiliac Trauma
13.3.1.1.
Motor
Vehicle Accident
13.3.1.2.
Fall on
Buttock
13.3.1.3.
Lifting
and/ or Twisting
13.3.1.4.
Natural
Childbirth
13.3.1.5.
Pregnancy
13.3.1.6.
Others
13.3.2. Sacroiliac Joint Degeneration
13.3.2.1.
Previous
Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
13.3.2.2.
Stresses
to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
13.3.2.3.
Osteoarthritis
13.3.2.4.
Previous
iliac Crest Bone Graft (ICBG)
13.3.2.5.
Prior
Infection of the SI joint
13.3.2.6.
Others
13.3.3. Others
13.4. Europe MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Treatments
13.4.1. Conservative Therapies
13.4.2. Non-Surgical SI Joint Treatment Options
13.4.2.1.
Pain
Medications (NSAIDs, opiods, or other medications)
13.4.2.2.
Chiropractic
Care
13.4.2.3.
Physical
Therapy
13.4.2.4.
Yoga
13.4.2.5.
Massage
Therapy
13.4.2.6.
Therapeutic
SI Joint Injections
13.4.2.7.
RF
Denervation or Radiofrequency Ablation (RFA)
13.4.2.8.
SI Joint
Belts
13.4.2.9.
Others
13.4.3. Minimally Invasive SI joint fusion Surgery
13.4.4. Open Surgery of Sacroiliac Joint Fusion
13.5. Europe MIS Sacroiliac Joint Fusion Market Revenue
(US$ Mn) and Forecasts, By End User
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Ambulatory Surgical Centers
13.5.4. Others
13.6. Europe MIS Sacroiliac Joint Fusion Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1.
France
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.1.1.1.
Provocative
Tests
13.6.1.1.1.1. Distraction
13.6.1.1.1.2. Thigh Thrust
13.6.1.1.1.3. Compression
13.6.1.1.1.4. FABER
13.6.1.1.1.5. Gaenslen
13.6.1.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.1.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.1.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.1.1.3.2. Post-injection Pain Reduction
13.6.1.2.
France
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
13.6.1.2.1.
Sacroiliac
Trauma
13.6.1.2.1.1. Motor Vehicle Accident
13.6.1.2.1.2. Fall on Buttock
13.6.1.2.1.3. Lifting and/ or Twisting
13.6.1.2.1.4. Natural Childbirth
13.6.1.2.1.5. Pregnancy
13.6.1.2.1.6. Others
13.6.1.2.2.
Sacroiliac
Joint Degeneration
13.6.1.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.1.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.1.2.2.3. Osteoarthritis
13.6.1.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.1.2.2.5. Prior Infection of the SI joint
13.6.1.2.2.6. Others
13.6.1.2.3.
Others
13.6.1.3.
France
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.1.3.1.
Conservative
Therapies
13.6.1.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.1.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.1.3.2.2. Chiropractic Care
13.6.1.3.2.3. Physical Therapy
13.6.1.3.2.4. Yoga
13.6.1.3.2.5. Massage Therapy
13.6.1.3.2.6. Therapeutic SI Joint Injections
13.6.1.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.1.3.2.8. SI Joint Belts
13.6.1.3.2.9. Others
13.6.1.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.1.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.1.4.
France
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
13.6.1.4.1.
Hospitals
13.6.1.4.2.
Clinics
13.6.1.4.3.
Ambulatory
Surgical Centers
13.6.1.4.4.
Others
13.6.2. The UK
13.6.2.1.
The UK
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.2.1.1.
Provocative
Tests
13.6.2.1.1.1. Distraction
13.6.2.1.1.2. Thigh Thrust
13.6.2.1.1.3. Compression
13.6.2.1.1.4. FABER
13.6.2.1.1.5. Gaenslen
13.6.2.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.2.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.2.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.2.1.3.2. Post-injection Pain Reduction
13.6.2.2.
The UK
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
13.6.2.2.1.
Sacroiliac
Trauma
13.6.2.2.1.1. Motor Vehicle Accident
13.6.2.2.1.2. Fall on Buttock
13.6.2.2.1.3. Lifting and/ or Twisting
13.6.2.2.1.4. Natural Childbirth
13.6.2.2.1.5. Pregnancy
13.6.2.2.1.6. Others
13.6.2.2.2.
Sacroiliac
Joint Degeneration
13.6.2.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.2.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.2.2.2.3. Osteoarthritis
13.6.2.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.2.2.2.5. Prior Infection of the SI joint
13.6.2.2.2.6. Others
13.6.2.2.3.
Others
13.6.2.3.
The UK
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.2.3.1.
Conservative
Therapies
13.6.2.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.2.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.2.3.2.2. Chiropractic Care
13.6.2.3.2.3. Physical Therapy
13.6.2.3.2.4. Yoga
13.6.2.3.2.5. Massage Therapy
13.6.2.3.2.6. Therapeutic SI Joint Injections
13.6.2.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.2.3.2.8. SI Joint Belts
13.6.2.3.2.9. Others
13.6.2.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.2.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.2.4.
The UK
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
13.6.2.4.1.
Hospitals
13.6.2.4.2.
Clinics
13.6.2.4.3.
Ambulatory
Surgical Centers
13.6.2.4.4.
Others
13.6.3. Spain
13.6.3.1.
Spain
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.3.1.1.
Provocative
Tests
13.6.3.1.1.1. Distraction
13.6.3.1.1.2. Thigh Thrust
13.6.3.1.1.3. Compression
13.6.3.1.1.4. FABER
13.6.3.1.1.5. Gaenslen
13.6.3.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.3.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.3.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.3.1.3.2. Post-injection Pain Reduction
13.6.3.2.
Spain
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
13.6.3.2.1.
Sacroiliac
Trauma
13.6.3.2.1.1. Motor Vehicle Accident
13.6.3.2.1.2. Fall on Buttock
13.6.3.2.1.3. Lifting and/ or Twisting
13.6.3.2.1.4. Natural Childbirth
13.6.3.2.1.5. Pregnancy
13.6.3.2.1.6. Others
13.6.3.2.2.
Sacroiliac
Joint Degeneration
13.6.3.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.3.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.3.2.2.3. Osteoarthritis
13.6.3.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.3.2.2.5. Prior Infection of the SI joint
13.6.3.2.2.6. Others
13.6.3.2.3.
Others
13.6.3.3.
Spain
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.3.3.1.
Conservative
Therapies
13.6.3.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.3.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.3.3.2.2. Chiropractic Care
13.6.3.3.2.3. Physical Therapy
13.6.3.3.2.4. Yoga
13.6.3.3.2.5. Massage Therapy
13.6.3.3.2.6. Therapeutic SI Joint Injections
13.6.3.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.3.3.2.8. SI Joint Belts
13.6.3.3.2.9. Others
13.6.3.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.3.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.3.4.
Spain
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
13.6.3.4.1.
Hospitals
13.6.3.4.2.
Clinics
13.6.3.4.3.
Ambulatory
Surgical Centers
13.6.3.4.4.
Others
13.6.4. Germany
13.6.4.1.
Germany
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.4.1.1.
Provocative
Tests
13.6.4.1.1.1. Distraction
13.6.4.1.1.2. Thigh Thrust
13.6.4.1.1.3. Compression
13.6.4.1.1.4. FABER
13.6.4.1.1.5. Gaenslen
13.6.4.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.4.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.4.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.4.1.3.2. Post-injection Pain Reduction
13.6.4.2.
Germany
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
13.6.4.2.1.
Sacroiliac
Trauma
13.6.4.2.1.1. Motor Vehicle Accident
13.6.4.2.1.2. Fall on Buttock
13.6.4.2.1.3. Lifting and/ or Twisting
13.6.4.2.1.4. Natural Childbirth
13.6.4.2.1.5. Pregnancy
13.6.4.2.1.6. Others
13.6.4.2.2.
Sacroiliac
Joint Degeneration
13.6.4.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.4.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.4.2.2.3. Osteoarthritis
13.6.4.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.4.2.2.5. Prior Infection of the SI joint
13.6.4.2.2.6. Others
13.6.4.2.3.
Others
13.6.4.3.
Germany
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.4.3.1.
Conservative
Therapies
13.6.4.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.4.3.2.1. Pain Medications (NSAIDs, opiods, or other medications)
13.6.4.3.2.2. Chiropractic Care
13.6.4.3.2.3. Physical Therapy
13.6.4.3.2.4. Yoga
13.6.4.3.2.5. Massage Therapy
13.6.4.3.2.6. Therapeutic SI Joint Injections
13.6.4.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.4.3.2.8. SI Joint Belts
13.6.4.3.2.9. Others
13.6.4.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.4.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.4.4.
Germany
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
13.6.4.4.1.
Hospitals
13.6.4.4.2.
Clinics
13.6.4.4.3.
Ambulatory
Surgical Centers
13.6.4.4.4.
Others
13.6.5. Italy
13.6.5.1.
Italy
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.5.1.1.
Provocative
Tests
13.6.5.1.1.1. Distraction
13.6.5.1.1.2. Thigh Thrust
13.6.5.1.1.3. Compression
13.6.5.1.1.4. FABER
13.6.5.1.1.5. Gaenslen
13.6.5.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.5.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.5.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.5.1.3.2. Post-injection Pain Reduction
13.6.5.2.
Italy
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
13.6.5.2.1.
Sacroiliac
Trauma
13.6.5.2.1.1. Motor Vehicle Accident
13.6.5.2.1.2. Fall on Buttock
13.6.5.2.1.3. Lifting and/ or Twisting
13.6.5.2.1.4. Natural Childbirth
13.6.5.2.1.5. Pregnancy
13.6.5.2.1.6. Others
13.6.5.2.2.
Sacroiliac
Joint Degeneration
13.6.5.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.5.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.5.2.2.3. Osteoarthritis
13.6.5.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.5.2.2.5. Prior Infection of the SI joint
13.6.5.2.2.6. Others
13.6.5.2.3.
Others
13.6.5.3.
Italy
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Treatments
13.6.5.3.1.
Conservative
Therapies
13.6.5.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.5.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.5.3.2.2. Chiropractic Care
13.6.5.3.2.3. Physical Therapy
13.6.5.3.2.4. Yoga
13.6.5.3.2.5. Massage Therapy
13.6.5.3.2.6. Therapeutic SI Joint Injections
13.6.5.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.5.3.2.8. SI Joint Belts
13.6.5.3.2.9. Others
13.6.5.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.5.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.5.4.
Italy
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
13.6.5.4.1.
Hospitals
13.6.5.4.2.
Clinics
13.6.5.4.3.
Ambulatory
Surgical Centers
13.6.5.4.4.
Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
13.6.6.1.1.
Provocative
Tests
13.6.6.1.1.1. Distraction
13.6.6.1.1.2. Thigh Thrust
13.6.6.1.1.3. Compression
13.6.6.1.1.4. FABER
13.6.6.1.1.5. Gaenslen
13.6.6.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.6.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.6.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.6.1.3.2. Post-injection Pain Reduction
13.6.6.2.
Nordic
Countries MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
13.6.6.2.1.
Sacroiliac
Trauma
13.6.6.2.1.1. Motor Vehicle Accident
13.6.6.2.1.2. Fall on Buttock
13.6.6.2.1.3. Lifting and/ or Twisting
13.6.6.2.1.4. Natural Childbirth
13.6.6.2.1.5. Pregnancy
13.6.6.2.1.6. Others
13.6.6.2.2.
Sacroiliac
Joint Degeneration
13.6.6.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.6.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.6.2.2.3. Osteoarthritis
13.6.6.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.6.2.2.5. Prior Infection of the SI joint
13.6.6.2.2.6. Others
13.6.6.2.3.
Others
13.6.6.3.
Nordic
Countries MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.6.3.1.
Conservative
Therapies
13.6.6.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.6.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.6.3.2.2. Chiropractic Care
13.6.6.3.2.3. Physical Therapy
13.6.6.3.2.4. Yoga
13.6.6.3.2.5. Massage Therapy
13.6.6.3.2.6. Therapeutic SI Joint Injections
13.6.6.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.6.3.2.8. SI Joint Belts
13.6.6.3.2.9. Others
13.6.6.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.6.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.6.4.
Nordic
Countries MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
End User
13.6.6.4.1.
Hospitals
13.6.6.4.2.
Clinics
13.6.6.4.3.
Ambulatory
Surgical Centers
13.6.6.4.4.
Others
13.6.6.5.
Nordic
Countries MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
13.6.7.1.1.
Provocative
Tests
13.6.7.1.1.1. Distraction
13.6.7.1.1.2. Thigh Thrust
13.6.7.1.1.3. Compression
13.6.7.1.1.4. FABER
13.6.7.1.1.5. Gaenslen
13.6.7.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.7.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.7.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.7.1.3.2. Post-injection Pain Reduction
13.6.7.2.
Benelux
Union MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
13.6.7.2.1.
Sacroiliac
Trauma
13.6.7.2.1.1. Motor Vehicle Accident
13.6.7.2.1.2. Fall on Buttock
13.6.7.2.1.3. Lifting and/ or Twisting
13.6.7.2.1.4. Natural Childbirth
13.6.7.2.1.5. Pregnancy
13.6.7.2.1.6. Others
13.6.7.2.2.
Sacroiliac
Joint Degeneration
13.6.7.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.7.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.7.2.2.3. Osteoarthritis
13.6.7.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.7.2.2.5. Prior Infection of the SI joint
13.6.7.2.2.6. Others
13.6.7.2.3.
Others
13.6.7.3.
Benelux
Union MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.7.3.1.
Conservative
Therapies
13.6.7.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.7.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.7.3.2.2. Chiropractic Care
13.6.7.3.2.3. Physical Therapy
13.6.7.3.2.4. Yoga
13.6.7.3.2.5. Massage Therapy
13.6.7.3.2.6. Therapeutic SI Joint Injections
13.6.7.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.7.3.2.8. SI Joint Belts
13.6.7.3.2.9. Others
13.6.7.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.7.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.7.4.
Benelux
Union MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.7.4.1.
Hospitals
13.6.7.4.2.
Clinics
13.6.7.4.3.
Ambulatory
Surgical Centers
13.6.7.4.4.
Others
13.6.7.5.
Benelux
Union MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
13.6.8.1.1.
Provocative
Tests
13.6.8.1.1.1. Distraction
13.6.8.1.1.2. Thigh Thrust
13.6.8.1.1.3. Compression
13.6.8.1.1.4. FABER
13.6.8.1.1.5. Gaenslen
13.6.8.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
13.6.8.1.3.
Diagnostic
SI Joint Injections of the SI Joint
13.6.8.1.3.1. Fluoroscopic Guided SI Joint Injection
13.6.8.1.3.2. Post-injection Pain Reduction
13.6.8.2.
Rest of
Europe MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
13.6.8.2.1.
Sacroiliac
Trauma
13.6.8.2.1.1. Motor Vehicle Accident
13.6.8.2.1.2. Fall on Buttock
13.6.8.2.1.3. Lifting and/ or Twisting
13.6.8.2.1.4. Natural Childbirth
13.6.8.2.1.5. Pregnancy
13.6.8.2.1.6. Others
13.6.8.2.2.
Sacroiliac
Joint Degeneration
13.6.8.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
13.6.8.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
13.6.8.2.2.3. Osteoarthritis
13.6.8.2.2.4. Previous iliac Crest Bone Graft (ICBG)
13.6.8.2.2.5. Prior Infection of the SI joint
13.6.8.2.2.6. Others
13.6.8.2.3.
Others
13.6.8.3.
Rest of
Europe MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
13.6.8.3.1.
Conservative
Therapies
13.6.8.3.2.
Non-Surgical
SI Joint Treatment Options
13.6.8.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
13.6.8.3.2.2. Chiropractic Care
13.6.8.3.2.3. Physical Therapy
13.6.8.3.2.4. Yoga
13.6.8.3.2.5. Massage Therapy
13.6.8.3.2.6. Therapeutic SI Joint Injections
13.6.8.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
13.6.8.3.2.8. SI Joint Belts
13.6.8.3.2.9. Others
13.6.8.3.3.
Minimally
Invasive SI joint fusion Surgery
13.6.8.3.4.
Open
Surgery of Sacroiliac Joint Fusion
13.6.8.4.
Rest of
Europe MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
End User
13.6.8.4.1.
Hospitals
13.6.8.4.2.
Clinics
13.6.8.4.3.
Ambulatory
Surgical Centers
13.6.8.4.4.
Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Diagnosis
13.7.3. By Cause
13.7.4. By Treatments
13.7.5. By End User
14. Asia Pacific MIS Sacroiliac Joint Fusion
Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Asia Pacific MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn)
14.2. Asia Pacific MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.2.1. Provocative Tests
14.2.1.1.
Distraction
14.2.1.2.
Thigh
Thrust
14.2.1.3.
Compression
14.2.1.4.
FABER
14.2.1.5.
Gaenslen
14.2.2. Diagnostic Imaging (X-ray, CT, MRI)
14.2.3. Diagnostic SI Joint Injections of the SI
Joint
14.2.3.1.
Fluoroscopic
Guided SI Joint Injection
14.2.3.2.
Post-injection
Pain Reduction
14.3. Asia Pacific MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Cause
14.3.1. Sacroiliac Trauma
14.3.1.1.
Motor
Vehicle Accident
14.3.1.2.
Fall on
Buttock
14.3.1.3.
Lifting
and/ or Twisting
14.3.1.4.
Natural
Childbirth
14.3.1.5.
Pregnancy
14.3.1.6.
Others
14.3.2. Sacroiliac Joint Degeneration
14.3.2.1.
Previous
Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
14.3.2.2.
Stresses
to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
14.3.2.3.
Osteoarthritis
14.3.2.4.
Previous
iliac Crest Bone Graft (ICBG)
14.3.2.5.
Prior
Infection of the SI joint
14.3.2.6.
Others
14.3.3. Others
14.4. Asia Pacific MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Treatments
14.4.1. Conservative Therapies
14.4.2. Non-Surgical SI Joint Treatment Options
14.4.2.1.
Pain
Medications (NSAIDs, opiods, or other medications)
14.4.2.2.
Chiropractic
Care
14.4.2.3.
Physical
Therapy
14.4.2.4.
Yoga
14.4.2.5.
Massage
Therapy
14.4.2.6.
Therapeutic
SI Joint Injections
14.4.2.7.
RF
Denervation or Radiofrequency Ablation (RFA)
14.4.2.8.
SI Joint
Belts
14.4.2.9.
Others
14.4.3. Minimally Invasive SI joint fusion Surgery
14.4.4. Open Surgery of Sacroiliac Joint Fusion
14.5. Asia Pacific MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Ambulatory Surgical Centers
14.5.4. Others
14.6. Asia Pacific MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1.
China
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.1.1.1.
Provocative
Tests
14.6.1.1.1.1. Distraction
14.6.1.1.1.2. Thigh Thrust
14.6.1.1.1.3. Compression
14.6.1.1.1.4. FABER
14.6.1.1.1.5. Gaenslen
14.6.1.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.1.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.1.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.1.1.3.2. Post-injection Pain Reduction
14.6.1.2.
China
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
14.6.1.2.1.
Sacroiliac
Trauma
14.6.1.2.1.1. Motor Vehicle Accident
14.6.1.2.1.2. Fall on Buttock
14.6.1.2.1.3. Lifting and/ or Twisting
14.6.1.2.1.4. Natural Childbirth
14.6.1.2.1.5. Pregnancy
14.6.1.2.1.6. Others
14.6.1.2.2.
Sacroiliac
Joint Degeneration
14.6.1.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.1.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.1.2.2.3. Osteoarthritis
14.6.1.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.1.2.2.5. Prior Infection of the SI joint
14.6.1.2.2.6. Others
14.6.1.2.3.
Others
14.6.1.3.
China
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.1.3.1.
Conservative
Therapies
14.6.1.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.1.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.1.3.2.2. Chiropractic Care
14.6.1.3.2.3. Physical Therapy
14.6.1.3.2.4. Yoga
14.6.1.3.2.5. Massage Therapy
14.6.1.3.2.6. Therapeutic SI Joint Injections
14.6.1.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.1.3.2.8. SI Joint Belts
14.6.1.3.2.9. Others
14.6.1.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.1.3.4.
Open
Surgery of Sacroiliac Joint Fusion
14.6.1.4.
China
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
14.6.1.4.1.
Hospitals
14.6.1.4.2.
Clinics
14.6.1.4.3.
Ambulatory
Surgical Centers
14.6.1.4.4.
Others
14.6.2. Japan
14.6.2.1.
Japan
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.2.1.1.
Provocative
Tests
14.6.2.1.1.1. Distraction
14.6.2.1.1.2. Thigh Thrust
14.6.2.1.1.3. Compression
14.6.2.1.1.4. FABER
14.6.2.1.1.5. Gaenslen
14.6.2.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.2.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.2.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.2.1.3.2. Post-injection Pain Reduction
14.6.2.2.
Japan
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
14.6.2.2.1.
Sacroiliac
Trauma
14.6.2.2.1.1. Motor Vehicle Accident
14.6.2.2.1.2. Fall on Buttock
14.6.2.2.1.3. Lifting and/ or Twisting
14.6.2.2.1.4. Natural Childbirth
14.6.2.2.1.5. Pregnancy
14.6.2.2.1.6. Others
14.6.2.2.2.
Sacroiliac
Joint Degeneration
14.6.2.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.2.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.2.2.2.3. Osteoarthritis
14.6.2.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.2.2.2.5. Prior Infection of the SI joint
14.6.2.2.2.6. Others
14.6.2.2.3.
Others
14.6.2.3.
Japan
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.2.3.1.
Conservative
Therapies
14.6.2.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.2.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.2.3.2.2. Chiropractic Care
14.6.2.3.2.3. Physical Therapy
14.6.2.3.2.4. Yoga
14.6.2.3.2.5. Massage Therapy
14.6.2.3.2.6. Therapeutic SI Joint Injections
14.6.2.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.2.3.2.8. SI Joint Belts
14.6.2.3.2.9. Others
14.6.2.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.2.3.4.
Open Surgery
of Sacroiliac Joint Fusion
14.6.2.4.
Japan
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
14.6.2.4.1.
Hospitals
14.6.2.4.2.
Clinics
14.6.2.4.3.
Ambulatory
Surgical Centers
14.6.2.4.4.
Others
14.6.3. India
14.6.3.1.
India
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.3.1.1.
Provocative
Tests
14.6.3.1.1.1. Distraction
14.6.3.1.1.2. Thigh Thrust
14.6.3.1.1.3. Compression
14.6.3.1.1.4. FABER
14.6.3.1.1.5. Gaenslen
14.6.3.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.3.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.3.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.3.1.3.2. Post-injection Pain Reduction
14.6.3.2.
India
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
14.6.3.2.1.
Sacroiliac
Trauma
14.6.3.2.1.1. Motor Vehicle Accident
14.6.3.2.1.2. Fall on Buttock
14.6.3.2.1.3. Lifting and/ or Twisting
14.6.3.2.1.4. Natural Childbirth
14.6.3.2.1.5. Pregnancy
14.6.3.2.1.6. Others
14.6.3.2.2.
Sacroiliac
Joint Degeneration
14.6.3.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.3.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.3.2.2.3. Osteoarthritis
14.6.3.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.3.2.2.5. Prior Infection of the SI joint
14.6.3.2.2.6. Others
14.6.3.2.3.
Others
14.6.3.3.
India
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.3.3.1.
Conservative
Therapies
14.6.3.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.3.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.3.3.2.2. Chiropractic Care
14.6.3.3.2.3. Physical Therapy
14.6.3.3.2.4. Yoga
14.6.3.3.2.5. Massage Therapy
14.6.3.3.2.6. Therapeutic SI Joint Injections
14.6.3.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.3.3.2.8. SI Joint Belts
14.6.3.3.2.9. Others
14.6.3.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.3.3.4.
Open
Surgery of Sacroiliac Joint Fusion
14.6.3.4.
India
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
14.6.3.4.1.
Hospitals
14.6.3.4.2.
Clinics
14.6.3.4.3.
Ambulatory
Surgical Centers
14.6.3.4.4.
Others
14.6.4. New Zealand
14.6.4.1.
New
Zealand MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
14.6.4.1.1.
Provocative
Tests
14.6.4.1.1.1. Distraction
14.6.4.1.1.2. Thigh Thrust
14.6.4.1.1.3. Compression
14.6.4.1.1.4. FABER
14.6.4.1.1.5. Gaenslen
14.6.4.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.4.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.4.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.4.1.3.2. Post-injection Pain Reduction
14.6.4.2.
New
Zealand MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
14.6.4.2.1.
Sacroiliac
Trauma
14.6.4.2.1.1. Motor Vehicle Accident
14.6.4.2.1.2. Fall on Buttock
14.6.4.2.1.3. Lifting and/ or Twisting
14.6.4.2.1.4. Natural Childbirth
14.6.4.2.1.5. Pregnancy
14.6.4.2.1.6. Others
14.6.4.2.2.
Sacroiliac
Joint Degeneration
14.6.4.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.4.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.4.2.2.3. Osteoarthritis
14.6.4.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.4.2.2.5. Prior Infection of the SI joint
14.6.4.2.2.6. Others
14.6.4.2.3.
Others
14.6.4.3.
New
Zealand MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.4.3.1.
Conservative
Therapies
14.6.4.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.4.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.4.3.2.2. Chiropractic Care
14.6.4.3.2.3. Physical Therapy
14.6.4.3.2.4. Yoga
14.6.4.3.2.5. Massage Therapy
14.6.4.3.2.6. Therapeutic SI Joint Injections
14.6.4.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.4.3.2.8. SI Joint Belts
14.6.4.3.2.9. Others
14.6.4.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.4.3.4.
Open
Surgery of Sacroiliac Joint Fusion
14.6.4.4.
New
Zealand MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
End User
14.6.4.4.1.
Hospitals
14.6.4.4.2.
Clinics
14.6.4.4.3.
Ambulatory
Surgical Centers
14.6.4.4.4.
Others
14.6.5. Australia
14.6.5.1.
Australia
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.5.1.1.
Provocative
Tests
14.6.5.1.1.1. Distraction
14.6.5.1.1.2. Thigh Thrust
14.6.5.1.1.3. Compression
14.6.5.1.1.4. FABER
14.6.5.1.1.5. Gaenslen
14.6.5.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.5.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.5.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.5.1.3.2. Post-injection Pain Reduction
14.6.5.2.
Australia
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
14.6.5.2.1.
Sacroiliac
Trauma
14.6.5.2.1.1. Motor Vehicle Accident
14.6.5.2.1.2. Fall on Buttock
14.6.5.2.1.3. Lifting and/ or Twisting
14.6.5.2.1.4. Natural Childbirth
14.6.5.2.1.5. Pregnancy
14.6.5.2.1.6. Others
14.6.5.2.2.
Sacroiliac
Joint Degeneration
14.6.5.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.5.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.5.2.2.3. Osteoarthritis
14.6.5.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.5.2.2.5. Prior Infection of the SI joint
14.6.5.2.2.6. Others
14.6.5.2.3.
Others
14.6.5.3.
Australia
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.5.3.1.
Conservative
Therapies
14.6.5.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.5.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.5.3.2.2. Chiropractic Care
14.6.5.3.2.3. Physical Therapy
14.6.5.3.2.4. Yoga
14.6.5.3.2.5. Massage Therapy
14.6.5.3.2.6. Therapeutic SI Joint Injections
14.6.5.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.5.3.2.8. SI Joint Belts
14.6.5.3.2.9. Others
14.6.5.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.5.3.4.
Open
Surgery of Sacroiliac Joint Fusion
14.6.5.4.
Australia
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
14.6.5.4.1.
Hospitals
14.6.5.4.2.
Clinics
14.6.5.4.3.
Ambulatory
Surgical Centers
14.6.5.4.4.
Others
14.6.6. South Korea
14.6.6.1.
South
Korea MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
14.6.6.1.1.
Provocative
Tests
14.6.6.1.1.1. Distraction
14.6.6.1.1.2. Thigh Thrust
14.6.6.1.1.3. Compression
14.6.6.1.1.4. FABER
14.6.6.1.1.5. Gaenslen
14.6.6.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.6.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.6.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.6.1.3.2. Post-injection Pain Reduction
14.6.6.2.
South
Korea MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
14.6.6.2.1.
Sacroiliac
Trauma
14.6.6.2.1.1. Motor Vehicle Accident
14.6.6.2.1.2. Fall on Buttock
14.6.6.2.1.3. Lifting and/ or Twisting
14.6.6.2.1.4. Natural Childbirth
14.6.6.2.1.5. Pregnancy
14.6.6.2.1.6. Others
14.6.6.2.2.
Sacroiliac
Joint Degeneration
14.6.6.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.6.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.6.2.2.3. Osteoarthritis
14.6.6.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.6.2.2.5. Prior Infection of the SI joint
14.6.6.2.2.6. Others
14.6.6.2.3.
Others
14.6.6.3.
South
Korea MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.6.3.1.
Conservative
Therapies
14.6.6.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.6.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.6.3.2.2. Chiropractic Care
14.6.6.3.2.3. Physical Therapy
14.6.6.3.2.4. Yoga
14.6.6.3.2.5. Massage Therapy
14.6.6.3.2.6. Therapeutic SI Joint Injections
14.6.6.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.6.3.2.8. SI Joint Belts
14.6.6.3.2.9. Others
14.6.6.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.6.3.4.
Open
Surgery of Sacroiliac Joint Fusion
14.6.6.4.
South
Korea MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.6.4.1.
Hospitals
14.6.6.4.2.
Clinics
14.6.6.4.3.
Ambulatory
Surgical Centers
14.6.6.4.4.
Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
14.6.7.1.1.
Provocative
Tests
14.6.7.1.1.1. Distraction
14.6.7.1.1.2. Thigh Thrust
14.6.7.1.1.3. Compression
14.6.7.1.1.4. FABER
14.6.7.1.1.5. Gaenslen
14.6.7.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.7.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.7.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.7.1.3.2. Post-injection Pain Reduction
14.6.7.2.
Southeast
Asia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
14.6.7.2.1.
Sacroiliac
Trauma
14.6.7.2.1.1. Motor Vehicle Accident
14.6.7.2.1.2. Fall on Buttock
14.6.7.2.1.3. Lifting and/ or Twisting
14.6.7.2.1.4. Natural Childbirth
14.6.7.2.1.5. Pregnancy
14.6.7.2.1.6. Others
14.6.7.2.2.
Sacroiliac
Joint Degeneration
14.6.7.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.7.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.7.2.2.3. Osteoarthritis
14.6.7.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.7.2.2.5. Prior Infection of the SI joint
14.6.7.2.2.6. Others
14.6.7.2.3.
Others
14.6.7.3.
Southeast
Asia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
14.6.7.3.1.
Conservative
Therapies
14.6.7.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.7.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.7.3.2.2. Chiropractic Care
14.6.7.3.2.3. Physical Therapy
14.6.7.3.2.4. Yoga
14.6.7.3.2.5. Massage Therapy
14.6.7.3.2.6. Therapeutic SI Joint Injections
14.6.7.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.7.3.2.8. SI Joint Belts
14.6.7.3.2.9. Others
14.6.7.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.7.3.4.
Open
Surgery of Sacroiliac Joint Fusion
14.6.7.4.
Southeast
Asia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.7.4.1.
Hospitals
14.6.7.4.2.
Clinics
14.6.7.4.3.
Ambulatory
Surgical Centers
14.6.7.4.4.
Others
14.6.7.5.
Southeast
Asia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts,
By Diagnosis
14.6.8.1.1.
Provocative
Tests
14.6.8.1.1.1. Distraction
14.6.8.1.1.2. Thigh Thrust
14.6.8.1.1.3. Compression
14.6.8.1.1.4. FABER
14.6.8.1.1.5. Gaenslen
14.6.8.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
14.6.8.1.3.
Diagnostic
SI Joint Injections of the SI Joint
14.6.8.1.3.1. Fluoroscopic Guided SI Joint Injection
14.6.8.1.3.2. Post-injection Pain Reduction
14.6.8.2.
Rest of
Asia Pacific MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts,
By Cause
14.6.8.2.1.
Sacroiliac
Trauma
14.6.8.2.1.1. Motor Vehicle Accident
14.6.8.2.1.2. Fall on Buttock
14.6.8.2.1.3. Lifting and/ or Twisting
14.6.8.2.1.4. Natural Childbirth
14.6.8.2.1.5. Pregnancy
14.6.8.2.1.6. Others
14.6.8.2.2.
Sacroiliac
Joint Degeneration
14.6.8.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
14.6.8.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
14.6.8.2.2.3. Osteoarthritis
14.6.8.2.2.4. Previous iliac Crest Bone Graft (ICBG)
14.6.8.2.2.5. Prior Infection of the SI joint
14.6.8.2.2.6. Others
14.6.8.2.3.
Others
14.6.8.3.
Rest of
Asia Pacific MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts,
By Treatments
14.6.8.3.1.
Conservative
Therapies
14.6.8.3.2.
Non-Surgical
SI Joint Treatment Options
14.6.8.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
14.6.8.3.2.2. Chiropractic Care
14.6.8.3.2.3. Physical Therapy
14.6.8.3.2.4. Yoga
14.6.8.3.2.5. Massage Therapy
14.6.8.3.2.6. Therapeutic SI Joint Injections
14.6.8.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
14.6.8.3.2.8. SI Joint Belts
14.6.8.3.2.9. Others
14.6.8.3.3.
Minimally
Invasive SI joint fusion Surgery
14.6.8.3.4.
Open Surgery
of Sacroiliac Joint Fusion
14.6.8.4.
Rest of
Asia Pacific MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts,
By End User
14.6.8.4.1.
Hospitals
14.6.8.4.2.
Clinics
14.6.8.4.3.
Ambulatory
Surgical Centers
14.6.8.4.4.
Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Diagnosis
14.7.3. By Cause
14.7.4. By Treatments
14.7.5. By End User
15. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Revenue (US$ Mn)
15.2. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.2.1. Provocative Tests
15.2.1.1.
Distraction
15.2.1.2.
Thigh
Thrust
15.2.1.3.
Compression
15.2.1.4.
FABER
15.2.1.5.
Gaenslen
15.2.2. Diagnostic Imaging (X-ray, CT, MRI)
15.2.3. Diagnostic SI Joint Injections of the SI
Joint
15.2.3.1.
Fluoroscopic
Guided SI Joint Injection
15.2.3.2.
Post-injection
Pain Reduction
15.3. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
15.3.1. Sacroiliac Trauma
15.3.1.1.
Motor
Vehicle Accident
15.3.1.2.
Fall on
Buttock
15.3.1.3.
Lifting
and/ or Twisting
15.3.1.4.
Natural
Childbirth
15.3.1.5.
Pregnancy
15.3.1.6.
Others
15.3.2. Sacroiliac Joint Degeneration
15.3.2.1.
Previous
Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
15.3.2.2.
Stresses
to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
15.3.2.3.
Osteoarthritis
15.3.2.4.
Previous
iliac Crest Bone Graft (ICBG)
15.3.2.5.
Prior
Infection of the SI joint
15.3.2.6.
Others
15.3.3. Others
15.4. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Revenue (US$ Mn) and Forecasts, By Treatments
15.4.1. Conservative Therapies
15.4.2. Non-Surgical SI Joint Treatment Options
15.4.2.1.
Pain
Medications (NSAIDs, opiods, or other medications)
15.4.2.2.
Chiropractic
Care
15.4.2.3.
Physical
Therapy
15.4.2.4.
Yoga
15.4.2.5.
Massage
Therapy
15.4.2.6.
Therapeutic
SI Joint Injections
15.4.2.7.
RF
Denervation or Radiofrequency Ablation (RFA)
15.4.2.8.
SI Joint
Belts
15.4.2.9.
Others
15.4.3. Minimally Invasive SI joint fusion Surgery
15.4.4. Open Surgery of Sacroiliac Joint Fusion
15.5. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Ambulatory Surgical Centers
15.5.4. Others
15.6. Middle East and Africa MIS Sacroiliac Joint
Fusion Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
15.6.1.1.1.
Provocative
Tests
15.6.1.1.1.1. Distraction
15.6.1.1.1.2. Thigh Thrust
15.6.1.1.1.3. Compression
15.6.1.1.1.4. FABER
15.6.1.1.1.5. Gaenslen
15.6.1.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
15.6.1.1.3.
Diagnostic
SI Joint Injections of the SI Joint
15.6.1.1.3.1. Fluoroscopic Guided SI Joint Injection
15.6.1.1.3.2. Post-injection Pain Reduction
15.6.1.2.
Saudi
Arabia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
15.6.1.2.1.
Sacroiliac
Trauma
15.6.1.2.1.1. Motor Vehicle Accident
15.6.1.2.1.2. Fall on Buttock
15.6.1.2.1.3. Lifting and/ or Twisting
15.6.1.2.1.4. Natural Childbirth
15.6.1.2.1.5. Pregnancy
15.6.1.2.1.6. Others
15.6.1.2.2.
Sacroiliac
Joint Degeneration
15.6.1.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
15.6.1.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
15.6.1.2.2.3. Osteoarthritis
15.6.1.2.2.4. Previous iliac Crest Bone Graft (ICBG)
15.6.1.2.2.5. Prior Infection of the SI joint
15.6.1.2.2.6. Others
15.6.1.2.3.
Others
15.6.1.3.
Saudi
Arabia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
15.6.1.3.1.
Conservative
Therapies
15.6.1.3.2.
Non-Surgical
SI Joint Treatment Options
15.6.1.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
15.6.1.3.2.2. Chiropractic Care
15.6.1.3.2.3. Physical Therapy
15.6.1.3.2.4. Yoga
15.6.1.3.2.5. Massage Therapy
15.6.1.3.2.6. Therapeutic SI Joint Injections
15.6.1.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
15.6.1.3.2.8. SI Joint Belts
15.6.1.3.2.9. Others
15.6.1.3.3.
Minimally
Invasive SI joint fusion Surgery
15.6.1.3.4.
Open
Surgery of Sacroiliac Joint Fusion
15.6.1.4.
Saudi
Arabia MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
End User
15.6.1.4.1.
Hospitals
15.6.1.4.2.
Clinics
15.6.1.4.3.
Ambulatory
Surgical Centers
15.6.1.4.4.
Others
15.6.2. UAE
15.6.2.1.
UAE MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.2.1.1.
Provocative
Tests
15.6.2.1.1.1. Distraction
15.6.2.1.1.2. Thigh Thrust
15.6.2.1.1.3. Compression
15.6.2.1.1.4. FABER
15.6.2.1.1.5. Gaenslen
15.6.2.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
15.6.2.1.3.
Diagnostic
SI Joint Injections of the SI Joint
15.6.2.1.3.1. Fluoroscopic Guided SI Joint Injection
15.6.2.1.3.2. Post-injection Pain Reduction
15.6.2.2.
UAE MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
15.6.2.2.1.
Sacroiliac
Trauma
15.6.2.2.1.1. Motor Vehicle Accident
15.6.2.2.1.2. Fall on Buttock
15.6.2.2.1.3. Lifting and/ or Twisting
15.6.2.2.1.4. Natural Childbirth
15.6.2.2.1.5. Pregnancy
15.6.2.2.1.6. Others
15.6.2.2.2.
Sacroiliac
Joint Degeneration
15.6.2.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
15.6.2.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
15.6.2.2.2.3. Osteoarthritis
15.6.2.2.2.4. Previous iliac Crest Bone Graft (ICBG)
15.6.2.2.2.5. Prior Infection of the SI joint
15.6.2.2.2.6. Others
15.6.2.2.3.
Others
15.6.2.3.
UAE MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Treatments
15.6.2.3.1.
Conservative
Therapies
15.6.2.3.2.
Non-Surgical
SI Joint Treatment Options
15.6.2.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
15.6.2.3.2.2. Chiropractic Care
15.6.2.3.2.3. Physical Therapy
15.6.2.3.2.4. Yoga
15.6.2.3.2.5. Massage Therapy
15.6.2.3.2.6. Therapeutic SI Joint Injections
15.6.2.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
15.6.2.3.2.8. SI Joint Belts
15.6.2.3.2.9. Others
15.6.2.3.3.
Minimally
Invasive SI joint fusion Surgery
15.6.2.3.4.
Open
Surgery of Sacroiliac Joint Fusion
15.6.2.4.
UAE MIS
Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
15.6.2.4.1.
Hospitals
15.6.2.4.2.
Clinics
15.6.2.4.3.
Ambulatory
Surgical Centers
15.6.2.4.4.
Others
15.6.3. Egypt
15.6.3.1.
Egypt
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.3.1.1.
Provocative
Tests
15.6.3.1.1.1. Distraction
15.6.3.1.1.2. Thigh Thrust
15.6.3.1.1.3. Compression
15.6.3.1.1.4. FABER
15.6.3.1.1.5. Gaenslen
15.6.3.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
15.6.3.1.3.
Diagnostic
SI Joint Injections of the SI Joint
15.6.3.1.3.1. Fluoroscopic Guided SI Joint Injection
15.6.3.1.3.2. Post-injection Pain Reduction
15.6.3.2.
Egypt
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
15.6.3.2.1.
Sacroiliac
Trauma
15.6.3.2.1.1. Motor Vehicle Accident
15.6.3.2.1.2. Fall on Buttock
15.6.3.2.1.3. Lifting and/ or Twisting
15.6.3.2.1.4. Natural Childbirth
15.6.3.2.1.5. Pregnancy
15.6.3.2.1.6. Others
15.6.3.2.2.
Sacroiliac
Joint Degeneration
15.6.3.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
15.6.3.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
15.6.3.2.2.3. Osteoarthritis
15.6.3.2.2.4. Previous iliac Crest Bone Graft (ICBG)
15.6.3.2.2.5. Prior Infection of the SI joint
15.6.3.2.2.6. Others
15.6.3.2.3.
Others
15.6.3.3.
Egypt
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
15.6.3.3.1.
Conservative
Therapies
15.6.3.3.2.
Non-Surgical
SI Joint Treatment Options
15.6.3.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
15.6.3.3.2.2. Chiropractic Care
15.6.3.3.2.3. Physical Therapy
15.6.3.3.2.4. Yoga
15.6.3.3.2.5. Massage Therapy
15.6.3.3.2.6. Therapeutic SI Joint Injections
15.6.3.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
15.6.3.3.2.8. SI Joint Belts
15.6.3.3.2.9. Others
15.6.3.3.3.
Minimally
Invasive SI joint fusion Surgery
15.6.3.3.4.
Open
Surgery of Sacroiliac Joint Fusion
15.6.3.4.
Egypt
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
15.6.3.4.1.
Hospitals
15.6.3.4.2.
Clinics
15.6.3.4.3.
Ambulatory
Surgical Centers
15.6.3.4.4.
Others
15.6.4. Kuwait
15.6.4.1.
Kuwait
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.4.1.1.
Provocative
Tests
15.6.4.1.1.1. Distraction
15.6.4.1.1.2. Thigh Thrust
15.6.4.1.1.3. Compression
15.6.4.1.1.4. FABER
15.6.4.1.1.5. Gaenslen
15.6.4.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
15.6.4.1.3.
Diagnostic
SI Joint Injections of the SI Joint
15.6.4.1.3.1. Fluoroscopic Guided SI Joint Injection
15.6.4.1.3.2. Post-injection Pain Reduction
15.6.4.2.
Kuwait
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
15.6.4.2.1.
Sacroiliac
Trauma
15.6.4.2.1.1. Motor Vehicle Accident
15.6.4.2.1.2. Fall on Buttock
15.6.4.2.1.3. Lifting and/ or Twisting
15.6.4.2.1.4. Natural Childbirth
15.6.4.2.1.5. Pregnancy
15.6.4.2.1.6. Others
15.6.4.2.2.
Sacroiliac
Joint Degeneration
15.6.4.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
15.6.4.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
15.6.4.2.2.3. Osteoarthritis
15.6.4.2.2.4. Previous iliac Crest Bone Graft (ICBG)
15.6.4.2.2.5. Prior Infection of the SI joint
15.6.4.2.2.6. Others
15.6.4.2.3.
Others
15.6.4.3.
Kuwait
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
15.6.4.3.1.
Conservative
Therapies
15.6.4.3.2.
Non-Surgical
SI Joint Treatment Options
15.6.4.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
15.6.4.3.2.2. Chiropractic Care
15.6.4.3.2.3. Physical Therapy
15.6.4.3.2.4. Yoga
15.6.4.3.2.5. Massage Therapy
15.6.4.3.2.6. Therapeutic SI Joint Injections
15.6.4.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
15.6.4.3.2.8. SI Joint Belts
15.6.4.3.2.9. Others
15.6.4.3.3.
Minimally
Invasive SI joint fusion Surgery
15.6.4.3.4.
Open
Surgery of Sacroiliac Joint Fusion
15.6.4.4.
Kuwait
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
15.6.4.4.1.
Hospitals
15.6.4.4.2.
Clinics
15.6.4.4.3.
Ambulatory
Surgical Centers
15.6.4.4.4.
Others
15.6.5. South Africa
15.6.5.1.
South
Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
15.6.5.1.1.
Provocative
Tests
15.6.5.1.1.1. Distraction
15.6.5.1.1.2. Thigh Thrust
15.6.5.1.1.3. Compression
15.6.5.1.1.4. FABER
15.6.5.1.1.5. Gaenslen
15.6.5.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
15.6.5.1.3.
Diagnostic
SI Joint Injections of the SI Joint
15.6.5.1.3.1. Fluoroscopic Guided SI Joint Injection
15.6.5.1.3.2. Post-injection Pain Reduction
15.6.5.2.
South
Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Cause
15.6.5.2.1.
Sacroiliac
Trauma
15.6.5.2.1.1. Motor Vehicle Accident
15.6.5.2.1.2. Fall on Buttock
15.6.5.2.1.3. Lifting and/ or Twisting
15.6.5.2.1.4. Natural Childbirth
15.6.5.2.1.5. Pregnancy
15.6.5.2.1.6. Others
15.6.5.2.2.
Sacroiliac
Joint Degeneration
15.6.5.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
15.6.5.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
15.6.5.2.2.3. Osteoarthritis
15.6.5.2.2.4. Previous iliac Crest Bone Graft (ICBG)
15.6.5.2.2.5. Prior Infection of the SI joint
15.6.5.2.2.6. Others
15.6.5.2.3.
Others
15.6.5.3.
South
Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
15.6.5.3.1.
Conservative
Therapies
15.6.5.3.2.
Non-Surgical
SI Joint Treatment Options
15.6.5.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
15.6.5.3.2.2. Chiropractic Care
15.6.5.3.2.3. Physical Therapy
15.6.5.3.2.4. Yoga
15.6.5.3.2.5. Massage Therapy
15.6.5.3.2.6. Therapeutic SI Joint Injections
15.6.5.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
15.6.5.3.2.8. SI Joint Belts
15.6.5.3.2.9. Others
15.6.5.3.3.
Minimally
Invasive SI joint fusion Surgery
15.6.5.3.4.
Open
Surgery of Sacroiliac Joint Fusion
15.6.5.4.
South
Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
End User
15.6.5.4.1.
Hospitals
15.6.5.4.2.
Clinics
15.6.5.4.3.
Ambulatory
Surgical Centers
15.6.5.4.4.
Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn)
and Forecasts, By Diagnosis
15.6.6.1.1.
Provocative
Tests
15.6.6.1.1.1. Distraction
15.6.6.1.1.2. Thigh Thrust
15.6.6.1.1.3. Compression
15.6.6.1.1.4. FABER
15.6.6.1.1.5. Gaenslen
15.6.6.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
15.6.6.1.3.
Diagnostic
SI Joint Injections of the SI Joint
15.6.6.1.3.1. Fluoroscopic Guided SI Joint Injection
15.6.6.1.3.2. Post-injection Pain Reduction
15.6.6.2.
Rest of
Middle East & Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn)
and Forecasts, By Cause
15.6.6.2.1.
Sacroiliac
Trauma
15.6.6.2.1.1. Motor Vehicle Accident
15.6.6.2.1.2. Fall on Buttock
15.6.6.2.1.3. Lifting and/ or Twisting
15.6.6.2.1.4. Natural Childbirth
15.6.6.2.1.5. Pregnancy
15.6.6.2.1.6. Others
15.6.6.2.2.
Sacroiliac
Joint Degeneration
15.6.6.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
15.6.6.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
15.6.6.2.2.3. Osteoarthritis
15.6.6.2.2.4. Previous iliac Crest Bone Graft (ICBG)
15.6.6.2.2.5. Prior Infection of the SI joint
15.6.6.2.2.6. Others
15.6.6.2.3.
Others
15.6.6.3.
Rest of
Middle East & Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn)
and Forecasts, By Treatments
15.6.6.3.1.
Conservative
Therapies
15.6.6.3.2.
Non-Surgical
SI Joint Treatment Options
15.6.6.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
15.6.6.3.2.2. Chiropractic Care
15.6.6.3.2.3. Physical Therapy
15.6.6.3.2.4. Yoga
15.6.6.3.2.5. Massage Therapy
15.6.6.3.2.6. Therapeutic SI Joint Injections
15.6.6.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
15.6.6.3.2.8. SI Joint Belts
15.6.6.3.2.9. Others
15.6.6.3.3.
Minimally
Invasive SI joint fusion Surgery
15.6.6.3.4.
Open
Surgery of Sacroiliac Joint Fusion
15.6.6.4.
Rest of
Middle East & Africa MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.6.4.1.
Hospitals
15.6.6.4.2.
Clinics
15.6.6.4.3.
Ambulatory
Surgical Centers
15.6.6.4.4.
Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Diagnosis
15.7.3. By Cause
15.7.4. By Treatments
15.7.5. By End User
16. Latin America MIS Sacroiliac Joint Fusion
Market Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Latin America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn)
16.2. Latin America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Diagnosis
16.2.1. Provocative Tests
16.2.1.1.
Distraction
16.2.1.2.
Thigh
Thrust
16.2.1.3.
Compression
16.2.1.4.
FABER
16.2.1.5.
Gaenslen
16.2.2. Diagnostic Imaging (X-ray, CT, MRI)
16.2.3. Diagnostic SI Joint Injections of the SI
Joint
16.2.3.1.
Fluoroscopic
Guided SI Joint Injection
16.2.3.2.
Post-injection
Pain Reduction
16.3. Latin America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Cause
16.3.1. Sacroiliac Trauma
16.3.1.1.
Motor
Vehicle Accident
16.3.1.2.
Fall on Buttock
16.3.1.3.
Lifting
and/ or Twisting
16.3.1.4.
Natural
Childbirth
16.3.1.5.
Pregnancy
16.3.1.6.
Others
16.3.2. Sacroiliac Joint Degeneration
16.3.2.1.
Previous
Lumbar Spine Surgery (e.g. fusion of the lumbar vertebrae)
16.3.2.2.
Stresses
to the SI Joint due to Leg Length Differences, Joint Replacement, or Scoliosis
16.3.2.3.
Osteoarthritis
16.3.2.4.
Previous
iliac Crest Bone Graft (ICBG)
16.3.2.5.
Prior
Infection of the SI joint
16.3.2.6.
Others
16.3.3. Others
16.4. Latin America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Treatments
16.4.1. Conservative Therapies
16.4.2. Non-Surgical SI Joint Treatment Options
16.4.2.1.
Pain
Medications (NSAIDs, opiods, or other medications)
16.4.2.2.
Chiropractic
Care
16.4.2.3.
Physical
Therapy
16.4.2.4.
Yoga
16.4.2.5.
Massage
Therapy
16.4.2.6.
Therapeutic
SI Joint Injections
16.4.2.7.
RF
Denervation or Radiofrequency Ablation (RFA)
16.4.2.8.
SI Joint
Belts
16.4.2.9.
Others
16.4.3. Minimally Invasive SI joint fusion Surgery
16.4.4. Open Surgery of Sacroiliac Joint Fusion
16.5. Latin America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By End User
16.5.1. Hospitals
16.5.2. Clinics
16.5.3. Ambulatory Surgical Centers
16.5.4. Others
16.6. Latin America MIS Sacroiliac Joint Fusion
Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
16.6.1.1.1.
Provocative
Tests
16.6.1.1.1.1. Distraction
16.6.1.1.1.2. Thigh Thrust
16.6.1.1.1.3. Compression
16.6.1.1.1.4. FABER
16.6.1.1.1.5. Gaenslen
16.6.1.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
16.6.1.1.3.
Diagnostic
SI Joint Injections of the SI Joint
16.6.1.1.3.1. Fluoroscopic Guided SI Joint Injection
16.6.1.1.3.2. Post-injection Pain Reduction
16.6.1.2.
Brazil
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
16.6.1.2.1.
Sacroiliac
Trauma
16.6.1.2.1.1. Motor Vehicle Accident
16.6.1.2.1.2. Fall on Buttock
16.6.1.2.1.3. Lifting and/ or Twisting
16.6.1.2.1.4. Natural Childbirth
16.6.1.2.1.5. Pregnancy
16.6.1.2.1.6. Others
16.6.1.2.2.
Sacroiliac
Joint Degeneration
16.6.1.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
16.6.1.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
16.6.1.2.2.3. Osteoarthritis
16.6.1.2.2.4. Previous iliac Crest Bone Graft (ICBG)
16.6.1.2.2.5. Prior Infection of the SI joint
16.6.1.2.2.6. Others
16.6.1.2.3.
Others
16.6.1.3.
Brazil
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
16.6.1.3.1.
Conservative
Therapies
16.6.1.3.2.
Non-Surgical
SI Joint Treatment Options
16.6.1.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
16.6.1.3.2.2. Chiropractic Care
16.6.1.3.2.3. Physical Therapy
16.6.1.3.2.4. Yoga
16.6.1.3.2.5. Massage Therapy
16.6.1.3.2.6. Therapeutic SI Joint Injections
16.6.1.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
16.6.1.3.2.8. SI Joint Belts
16.6.1.3.2.9. Others
16.6.1.3.3.
Minimally
Invasive SI joint fusion Surgery
16.6.1.3.4.
Open
Surgery of Sacroiliac Joint Fusion
16.6.1.4.
Brazil
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
16.6.1.4.1.
Hospitals
16.6.1.4.2.
Clinics
16.6.1.4.3.
Ambulatory
Surgical Centers
16.6.1.4.4.
Others
16.6.2. Argentina
16.6.2.1.
Argentina
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Diagnosis
16.6.2.1.1.
Provocative
Tests
16.6.2.1.1.1. Distraction
16.6.2.1.1.2. Thigh Thrust
16.6.2.1.1.3. Compression
16.6.2.1.1.4. FABER
16.6.2.1.1.5. Gaenslen
16.6.2.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
16.6.2.1.3.
Diagnostic
SI Joint Injections of the SI Joint
16.6.2.1.3.1. Fluoroscopic Guided SI Joint Injection
16.6.2.1.3.2. Post-injection Pain Reduction
16.6.2.2.
Argentina
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By Cause
16.6.2.2.1.
Sacroiliac
Trauma
16.6.2.2.1.1. Motor Vehicle Accident
16.6.2.2.1.2. Fall on Buttock
16.6.2.2.1.3. Lifting and/ or Twisting
16.6.2.2.1.4. Natural Childbirth
16.6.2.2.1.5. Pregnancy
16.6.2.2.1.6. Others
16.6.2.2.2.
Sacroiliac
Joint Degeneration
16.6.2.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
16.6.2.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
16.6.2.2.2.3. Osteoarthritis
16.6.2.2.2.4. Previous iliac Crest Bone Graft (ICBG)
16.6.2.2.2.5. Prior Infection of the SI joint
16.6.2.2.2.6. Others
16.6.2.2.3.
Others
16.6.2.3.
Argentina
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By
Treatments
16.6.2.3.1.
Conservative
Therapies
16.6.2.3.2.
Non-Surgical
SI Joint Treatment Options
16.6.2.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
16.6.2.3.2.2. Chiropractic Care
16.6.2.3.2.3. Physical Therapy
16.6.2.3.2.4. Yoga
16.6.2.3.2.5. Massage Therapy
16.6.2.3.2.6. Therapeutic SI Joint Injections
16.6.2.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
16.6.2.3.2.8. SI Joint Belts
16.6.2.3.2.9. Others
16.6.2.3.3.
Minimally
Invasive SI joint fusion Surgery
16.6.2.3.4.
Open
Surgery of Sacroiliac Joint Fusion
16.6.2.4.
Argentina
MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and Forecasts, By End User
16.6.2.4.1.
Hospitals
16.6.2.4.2.
Clinics
16.6.2.4.3.
Ambulatory
Surgical Centers
16.6.2.4.4.
Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
16.6.3.1.1.
Provocative
Tests
16.6.3.1.1.1. Distraction
16.6.3.1.1.2. Thigh Thrust
16.6.3.1.1.3. Compression
16.6.3.1.1.4. FABER
16.6.3.1.1.5. Gaenslen
16.6.3.1.2.
Diagnostic
Imaging (X-ray, CT, MRI)
16.6.3.1.3.
Diagnostic
SI Joint Injections of the SI Joint
16.6.3.1.3.1. Fluoroscopic Guided SI Joint Injection
16.6.3.1.3.2. Post-injection Pain Reduction
16.6.3.2.
Rest of
Latin America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By Cause
16.6.3.2.1.
Sacroiliac
Trauma
16.6.3.2.1.1. Motor Vehicle Accident
16.6.3.2.1.2. Fall on Buttock
16.6.3.2.1.3. Lifting and/ or Twisting
16.6.3.2.1.4. Natural Childbirth
16.6.3.2.1.5. Pregnancy
16.6.3.2.1.6. Others
16.6.3.2.2.
Sacroiliac
Joint Degeneration
16.6.3.2.2.1. Previous Lumbar Spine Surgery (e.g. fusion of
the lumbar vertebrae)
16.6.3.2.2.2. Stresses to the SI Joint due to Leg Length
Differences, Joint Replacement, or Scoliosis
16.6.3.2.2.3. Osteoarthritis
16.6.3.2.2.4. Previous iliac Crest Bone Graft (ICBG)
16.6.3.2.2.5. Prior Infection of the SI joint
16.6.3.2.2.6. Others
16.6.3.2.3.
Others
16.6.3.3.
Rest of
Latin America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By Treatments
16.6.3.3.1.
Conservative
Therapies
16.6.3.3.2.
Non-Surgical
SI Joint Treatment Options
16.6.3.3.2.1. Pain Medications (NSAIDs, opiods, or other
medications)
16.6.3.3.2.2. Chiropractic Care
16.6.3.3.2.3. Physical Therapy
16.6.3.3.2.4. Yoga
16.6.3.3.2.5. Massage Therapy
16.6.3.3.2.6. Therapeutic SI Joint Injections
16.6.3.3.2.7. RF Denervation or Radiofrequency Ablation
(RFA)
16.6.3.3.2.8. SI Joint Belts
16.6.3.3.2.9. Others
16.6.3.3.3.
Minimally
Invasive SI joint fusion Surgery
16.6.3.3.4.
Open
Surgery of Sacroiliac Joint Fusion
16.6.3.4.
Rest of
Latin America MIS Sacroiliac Joint Fusion Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.3.4.1.
Hospitals
16.6.3.4.2.
Clinics
16.6.3.4.3.
Ambulatory
Surgical Centers
16.6.3.4.4.
Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Diagnosis
16.7.3. By Cause
16.7.4. By Treatments
16.7.5. By End User
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Globus Medical
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Life Spine, Inc.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Medtronic
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Orthofix Medical Inc.
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. SI-BONE, Inc.
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Surgalign
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. VGI MEDICAL
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. XTANT MEDICAL
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Zimmer Biomet
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Other Market Participants
19. Key Findings
Note:
This ToC is tentative and can be changed according to the research study
conducted during the course of report completion.
**Exclusive
for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.